Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Natera, Inc. NTRA

Healthcare  —  Diagnostics & Research
412.56 3.77 0.92% as of 25 Sep
Market cap
$59.2B
P/E
0.0×
Cash Flow Champion (3y)
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K
Quarterly (Descending) Quarterly (Ascending) Annual (Descending) Annual (Ascending) TTM (Descending) TTM (Ascending)
Download Excel — free account
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE (12.54%) (15.02%) (14.32%) (29.02%)

+8 more TTM periods
ROA (8.71%) (10.41%) (10.26%) (18.12%)
ROIC (22.34%) (26.44%) (27.03%) (75.81%)
Return on Tangible Assets (13.51%) (16.60%) (16.05%) (25.51%)
Average Days of Receivables 56.89 60.95 46.93 49.38
Free Cash Flow per Share 0.59 0.74 0.80 0.77
Free Cash Flow 84.20 104.51 109.11 106.07
Capital Expenditures (144.04) (106.51) (106.19) (88.23)
Piotroski F-Score 6.00 6.00 6.00 5.00
Other line items
Cash ROIC 7.63% 7.17% 7.50% 8.18%
Accounts Receivable Turnover 7.40 6.80 7.55 7.14
Accounts Payable Turnover 16.80 17.19 23.88 20.70
Inventory Turnover 13.98 14.43 14.36 13.57
Average Days of Payables 29.14 26.07 14.89 22.06
Days of Inventory on Hand 31.16 29.55 30.73 30.67
Tax Rate (0.24) (0.21) (0.22) 0.00
Research and Development Expense of Revenue 29.09% 28.22% 27.06% 27.32%
Selling, General and Administrative Expense of Revenue 46.36% 49.52% 51.05% 52.95%
Share Based Compensation of Revenue 14.09% 14.86% 15.37% 15.77%
Interest Coverage 0.00 0.00 0.00 0.00
Operating CF/Net income (1.19) (0.93) (1.03) (0.63)
Depreciation/Fixed assets 0.21 0.20 0.18 0.18
Capex/Depreciation (2.19) (1.95) (2.44) (2.37)
Revenue per Share 18.89 17.67 16.87 15.43
Operating CF per Share 1.59 1.49 1.57 1.42
Capex per Share (1.01) (0.75) (0.78) (0.64)
Capex to Sales 0.05 0.04 0.05 0.04
Net Profit Margin (7.11%) (9.05%) (9.03%) (14.61%)

Fold the line items

Columns are period end dates